Initial testing of AstraZeneca’s nasal spray COVID vaccine yields underwhelming results

October 18, 2022

Vanda Challenges FDA Over Limits on Off-Label Drug Communication

April 16, 2025

Most life sciences executives say digital delivery of drugs is the future of health

May 8, 2021

Must Read

FDA Requests Withdrawal of Intercept’s Ocaliva from U.S. Market

September 11, 2025

FDA Approves Inlexzo, Johnson & Johnson’s Breakthrough Bladder Cancer Therapy

September 11, 2025

Sanofi’s Amlitelimab Meets Trial Targets but Falls Short of Analyst Expectations

September 11, 2025

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Pfizer to Withdraw Vyndaqel in the U.S. Before Patent Expiration in 2028

Roche Ends Development of Obesity Candidate CT-173 and Discontinues Multiple Early-Stage Programs

$20 Million Pediatric CRISPR Center Launched to Develop Treatments for Rare Genetic Diseases

Scientists Identify New Target to Prevent Cancer from Spreading to Bones

Sanofi’s Amlitelimab Meets Trial Targets but Falls Short of Analyst Expectations

BioNTech’s HER2 ADC Scores Win In Phase 3 Breast Cancer Trial

Eli Lilly’s Jaypirca Demonstrates Strong Results in Phase 3 CLL Trial

BioNTech and Bristol Myers Squibb Present Global Phase 2 Data for Pumitamig in Small Cell Lung Cancer

Vertex and Enlaza Form $2 Billion Drug Discovery Alliance Focused on Autoimmune and Blood Disorders

BeOne Announces $950M Royalty Deal For Amgen’s Imdelltra

AbbVie Acquires Gilgamesh’s Lead Psychedelic Drug Candidate for Up to $1.2 Billion

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Reg impact assessment next in GenAI’s sights, experts claim

The now-urgent automation agenda: out-of-control regulatory workloads necessitate AI adoption

Improving life science R&D outcomes with AI

The medical device sector’s surging regulatory burden: how are suppliers coping?

News

China forces insulin price cuts resulting in pullback for global pharma players

Aussie pharma CSL in talks to buy Swiss firm Vifor Pharma for USD 7B

Sanofi to acquire Origimm Biotechnology in a bid to expand vaccine pipeline

Is Biogen’s Alzheimer’s drug worth $56K? Experts say $8400 and raise questions about efficacy

AstraZeneca and FibroGen hit FDA committee’s safety data firewall for roxadustat

NRx Pharmaceuticals signs deal for clinical trials of Israel’s homegrown Covid-19...

Editor Picks

Initial testing of AstraZeneca’s nasal spray COVID vaccine yields underwhelming results

Vanda Challenges FDA Over Limits on Off-Label Drug Communication

Most life sciences executives say digital delivery of drugs is the future of health

Must Read

FDA Requests Withdrawal of Intercept’s Ocaliva from U.S. Market

FDA Approves Inlexzo, Johnson & Johnson’s Breakthrough Bladder Cancer Therapy

Sanofi’s Amlitelimab Meets Trial Targets but Falls Short of Analyst Expectations

Hot Topics

About Us

Follow Us